Getting Booked - Stat

Article

Gaining access to that top-notch doctor or medical center can present a larger hurdle for someone with an uncommon malignancy, but it is possible with a few tips.

Gaining access to that top-notch doctor or medical center, never easy for any patient, can present a larger hurdle for someone with an uncommon malignancy, says Marty Rosen, executive vice president of marketing and cofounder at Health Advocate, in Pennsylvania, which provides health advocacy, wellness and other services.

“I think that the challenge is probably exacerbated for these people who have rarer or esoteric disease, for no other reason than that there is probably a smaller universe of these providers, especially top docs or top centers of excellence,” Rosen says. “That probably creates even more of a potential logjam.”

Given the challenges involved, Rosen and others who work with patients advise them to gather key medical information in advance and prepare to make their most compelling case.

Ideally, the patient’s local doctor should call on the patient’s behalf, Rosen says. If that’s not feasible, a close family member might be the next best choice, to advocate non-emotionally and articulately to a busy office assistant who is triaging a multitude of ill patients, he says. In just a few sentences, spell out what tests have been conducted, the precise diagnosis and why time is of the essence, he says.

Be sure to have all of the scans and medical records gathered digitally, so they can be imme- diately transmitted, says Marion Schwartz, chief advocacy officer at the Cholangiocarcinoma (bile duct cancer) Foundation. Request a digital copy of every test as soon as it’s been completed. In some cases, the actual tissue (known as a “block”) may be needed to perform specialized diagnostic tests to determine the tumor type.

Patients can also compare strategies online, whether it’s getting access to an off-label medi- cation or an overbooked physician, says Beth McNaughton, vice president of community for Inspire.com, which provides links to 200 online support groups. “It’s kind of like tips and tricks,” she says. “They’ll ask if there’s some way to get around it, or to get prioritized.”

Prepare to be polite, but persistent, Schwartz stresses. “Re-contact, re-email, re-call,” she says. “Call daily until you are heard.”

[Read "Rare Finds" on finding support and medical options when you have a rare cancer]

Related Videos
For patients with cancer, the ongoing chemotherapy shortage may cause some anxiety as they wonder how they will receive their drugs. However, measuring drugs “down to the minutiae of the milligrams” helped patients receive the drugs they needed, said Alison Tray. Tray is an advanced oncology certified nurse practitioner and current vice president of ambulatory operations at Rutgers Cancer Institute in New Jersey.  If patients are concerned about getting their cancer drugs, Tray noted that having “an open conversation” between patients and providers is key.  “As a provider and a nurse myself, having that conversation, that reassurance and sharing the information is a two-way conversation,” she said. “So just knowing that we're taking care of you, we're going to make sure that you receive the care that you need is the key takeaway.” In June 2023, many patients were unable to receive certain chemotherapy drugs, such as carboplatin and cisplatin because of an ongoing shortage. By October 2023, experts saw an improvement, although the “ongoing crisis” remained.  READ MORE: Patients With Lung Cancer Face Unmet Needs During Drug Shortages “We’re really proud of the work that we could do and achieve that through a critical drug shortage,” Tray said. “None of our patients missed a dose of chemotherapy and we were able to provide that for them.” Tray sat down with CURE® during the 49th Annual Oncology Nursing Society Annual Congress to discuss the ongoing chemo shortage and how patients and care teams approached these challenges. Transcript: Particularly at Hartford HealthCare, when we established this infrastructure, our goal was to make sure that every patient would get the treatment that they need and require, utilizing the data that we have from ASCO guidelines to ensure that we're getting the optimal high-quality standard of care in a timely fashion that we didn't have to delay therapies. So, we were able to do that by going down to the minutiae of the milligrams on hand, particularly when we had a lot of critical drug shortages. So it was really creating that process to really ensure that every patient would get the treatment that they needed. For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.
Yuliya P.L Linhares, MD, an expert on CLL
Yuliya P.L Linhares, MD, and Josie Montegaard, MSN, AGPCNP-BC, experts on CLL
Image of a man with a beard.
Image of a man with gray facial hair and a navy blue suit with a light orange tie.
Image of a woman with black hair.
Related Content